You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Nuclear IRF-1 expression as a mechanism to assess “Capability” to express PD-L1 and response to PD-1 therapy in metastatic melanoma

Article metrics

Article menu

Download PDFPDF

Research Article
Nuclear IRF-1 expression as a mechanism to assess “Capability” to express PD-L1 and response to PD-1 therapy in metastatic melanoma

 

Online download statistics by month:

Online download statistics by month: December 2019 to June 2025

AbstractFullPdf
Dec 2019550
Jan 2020551
Feb 202012121
Mar 202028284
Apr 202020204
May 2020404010
Jun 202029293
Jul 202016166
Aug 202018164
Sep 202028285
Oct 2020383810
Nov 202027265
Dec 202015158
Jan 202114142
Feb 202116163
Mar 2021212110
Apr 202116169
May 2021550
Jun 202114142
Jul 202116166
Aug 2021662
Sep 202120204
Oct 2021883
Nov 202125255
Dec 202121216
Jan 202220214
Feb 202210103
Mar 202214166
Apr 202214152
May 202225250
Jun 202231311
Jul 202232331
Aug 202232322
Sep 202230304
Oct 202230303
Nov 2022141614
Dec 202221212
Jan 202316162
Feb 202335352
Mar 202324252
Apr 202317181
May 202311112
Jun 202312121
Jul 2023442
Aug 202314143
Sep 202318182
Oct 202389891
Nov 20231931935
Dec 202388883
Jan 202462636
Feb 202415153
Mar 202416163
Apr 202423244
May 2024992
Jun 202416165
Jul 202428298
Aug 202411115
Sep 202410105
Oct 2024161611
Nov 202417183
Dec 202417173
Jan 2025191915
Feb 202514142
Mar 2025252510
Apr 2025535311
May 202516167
Jun 202521214
Total16451655288